Trial intelligence / Profile preview

Metformin versus diabetes-model antenatal care for mild fasting hyperglycaemia in pregnancy

2013-004065-13Phase 4Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM) and impaired glucose tolerance (IGT) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoints: Recruitment rate and Acceptability of intervention. Started Oct 2013; status: completed.

02

Drugs

metformin
03

Conditions

gestational diabetes mellitus (GDM)impaired glucose tolerance (IGT)

Beyond the preview

Go deeper on 2013-004065-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004065-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call